Published in Ann Oncol on May 29, 2013
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol (2015) 1.45
A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLoS One (2014) 0.92
Diabetes mellitus and metformin in hepatocellular carcinoma. World J Gastroenterol (2016) 0.82
Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. Nutrients (2014) 0.82
Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk. Gastroenterol Res Pract (2015) 0.79
Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma. World J Hepatol (2015) 0.78
Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? World J Gastroenterol (2016) 0.76
Body Mass Index, Waist Circumference, Diabetes, and Risk of Liver Cancer for U.S. Adults. Cancer Res (2016) 0.76
Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma. Sci Rep (2016) 0.76
PATHOGENESIS OF HEPATOCELLULAR CARCINOMA DEVELOPMENT IN NON ALCOHOLIC FATTY LIVER DISEASE. Curr Hepatol Rep (2015) 0.75
Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies. Med Sci Monit Basic Res (2016) 0.75
HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus. J Diabetes Res (2017) 0.75
Higher Glucose and Insulin Levels Are Associated with Risk of Liver Cancer and Chronic Liver Disease Mortality among Men without a History of Diabetes. Cancer Prev Res (Phila) (2016) 0.75
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease. Ann Transl Med (2017) 0.75
Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. Eur J Nutr (2014) 0.75
Diabetes and the Pancreatobiliary Diseases. Curr Treat Options Gastroenterol (2017) 0.75
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology (2004) 5.83
Epidemiology of non-alcoholic fatty liver disease. Dig Dis (2010) 3.44
Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer (2006) 3.27
Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr (2005) 3.21
Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst (2011) 2.63
Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev (2012) 2.38
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer (2010) 2.04
Accuracy of self-reported diabetes, hypertension and hyperlipidemia in the adult Spanish population. DINO study findings. Rev Esp Cardiol (2009) 1.98
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer (2011) 1.69
Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia (2011) 1.62
Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer (2006) 1.58
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol (2008) 1.44
Targeting insulin-like growth factor axis in hepatocellular carcinoma. J Hematol Oncol (2011) 1.22
Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.18
Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort. Int J Cancer (2012) 1.15
Diabetes mellitus and the risk of primary liver cancer. Int J Cancer (1997) 1.15
Metabolic syndrome and hepatocellular carcinoma risk. Br J Cancer (2012) 1.09
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma. World J Gastroenterol (2010) 1.02
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr Pharm Des (2010) 1.01
Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control (2011) 1.00
Diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans. World J Gastroenterol (2009) 0.97
Diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China. Br J Cancer (2010) 0.94
Presence of gallstones or kidney stones and risk of type 2 diabetes. Am J Epidemiol (2010) 0.89
Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control (2012) 0.87
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia (2005) 4.87
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85
The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol (1997) 4.73
Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr (1995) 4.50
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer (1986) 4.11
Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer (1989) 4.01
Transcriptional silencing and thermoregulation of gene expression in Escherichia coli. Nature (1990) 3.96
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst (1998) 3.74
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell (1990) 3.29
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond) (2011) 2.93
Milk consumption and bone mineral density in middle aged and elderly women. BMJ (1994) 2.85
A transcriptional roadmap to wood formation. Proc Natl Acad Sci U S A (2001) 2.85
Functional food science and gastrointestinal physiology and function. Br J Nutr (1998) 2.78
Risk factors for cervical cancer in Colombia and Spain. Int J Cancer (1992) 2.75
The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. BMJ (1990) 2.71
Residential area deprivation predicts smoking habit independently of individual educational level and occupational social class. A cross sectional study in the Norfolk cohort of the European Investigation into Cancer (EPIC-Norfolk). J Epidemiol Community Health (2003) 2.66
Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care (2000) 2.63
Comparison of nutrients in the food composition tables available in the nine European countries participating in EPIC. European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr (1999) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med (1996) 2.55
Effect of alcohol consumption on systemic markers of inflammation. Lancet (2001) 2.52
Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity. J Intern Med (2000) 2.51
Where are the women in studies of coronary heart disease? BMJ (1993) 2.46
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens (1993) 2.40
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst (2000) 2.34
Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis (1992) 2.31
A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill (2006) 2.30
The complications of trabeculectomy (a 20-year follow-up). Eye (Lond) (1990) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25